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Events that control developmental changes occur during specific windows of gestation and if disrupted, can lead to dys-
morphogenesis or embryolethality. One largely understudied aspect of developmental control is redox regulation, where
the untimely disruption of intracellular redox potentials (Eh) may alter development, suggesting that tight control of
developmental-stage–specific redox states is necessary to support normal development. In this study, mouse gestational
day 8.5 embryos in whole embryo culture were treated with 10 M dithiole-3-thione (D3T), an inducer of nuclear factor
(erythroid-derived 2)-like 2 (Nrf2). After 14 hr, D3T-treated and -untreated conceptuses were challenged with 200 M
hydrogen peroxide (H2O2) to induce oxidant-induced change to intracellular Ehs. Redox potentials of glutathione (GSH),
thioredoxin-1 (Trx1), and mitochondrial thioredoxin-2 (Trx2) were then measured over a 2-hr rebounding period fol-
lowing H2O2 treatment. D3T treatment increased embryonic expression of known Nrf2-regulated genes, including those
responsible for redox regulation of major intracellular redox couples. Exposure to H2O2 without prior D3T treatment
produced significant oxidation of GSH, Trx1, and Trx2, based on Eh values, where GSH and Trx2 Eh recovered, reach-
ing to pre-H2O2 Eh ranges, but Trx1 Eh remained oxidized. Following H2O2 addition in culture to embryos that received
D3T pretreatments, GSH, Trx1, and Trx2 were insulated from significant oxidation. These data show that Nrf2 activa-
tion may serve as a means to protect the embryo from chemically induced oxidative stress through the preservation of
intracellular redox states during development, allowing normal morphogenesis to ensue. Birth Defects Res (Part B) 95:213–218,
2012. C© 2012 Wiley Periodicals, Inc.
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INTRODUCTION
Recent work has highlighted the redox control of many
different developmental processes. Cellular proliferation,
differentiation, and apoptosis are tightly controlled by in-
tracellular redox potentials (Eh), and chemically induced
perturbation of Eh causes changes in these endpoints
(Ranganna et al., 2007; Yan et al., 2009; Anathy et al.,
2011). Most published work on redox regulation has pri-
marily focused on events related to disease pathologies
and has not directly addressed them during development.
Since development is a combination of several molecular
events that occur in a temporally coordinated manner, it
is proposed that disruption of one or more of these events
could, in turn, lead to a developmental deficit or birth de-
fect (Hansen, 2006).
There are many teratogens that induce oxidative stress
en route to producing adverse birth outcomes. The pro-
totype teratogen thalidomide, for example, produces lit-
tle cell death in embryos at teratogenic concentrations but
still alters the developmental programing leading to limb
dysmorphogenesis. In the past 15 years, many studies
have shown that thalidomide effects have been shown to
be caused primarily by the generation of reactive oxygen
species (ROS) and disruption of redox signaling (Sauer
et al., 2000; Hansen et al., 2002), suggesting that a pri-
mary oxidative mechanism by which some teratogens ex-
ert their effect is through the oxidative dysregulation of
signaling.
In addition, many studies have shown the beneficial
effects of antioxidant supplementation against teratogen-
induced outcomes. The teratogenic effects of some of the
most relevant teratogens to humans, such as ethanol,
methyl mercury, and thalidomide, are all diminished
through treatments with various antioxidants (Ornaghi
et al., 1993; Parman et al., 1999; Parnell et al., 2010), sug-
gesting that the maintenance of normal Eh values are crit-
ical for normal development.
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Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is
a transcription factor that activates the antioxidant
response in cells and upregulates many genes associated
with the regulation of intracellular redox states and ROS
detoxification (Kwak et al., 2002; Thimmulappa et al.,
2002). The purpose of the present study was to deter-
mine if Nrf2 activation in the embryo protects against
subsequent oxidant-induced disruption of intracellular
redox couples. Since certain redox couples regulate spe-
cific aspects of important signaling pathways, we have
focused this study on the glutathione (GSH) and thiore-
doxin (both thioredoxin-1 [Trx1] and thioredoxin-2 [Trx2])
systems. Here, we demonstrate the effectiveness of Nrf2-
mediated protection from oxidant-induced redox dysreg-
ulation in organogenesis-stagedmouse embryos, suggest-
ing a means by which teratogenesis may be mitigated.
METHODS
Animals and Whole Embryo Culture
Time-mated primagravida CD-1 (ICR) mice (ages 8–12
weeks) were purchased from Taconic (Hudson, NY) and
were shipped directly to Emory University. Gestational
day (GD) was assigned upon evidence of mating, with
GD 0 beginning the morning following copulation and
the discovery of a vaginal plug. Animals were cared for
by the Division of Animal Resources at Emory Univer-
sity under a 12 hr/12 hr light/dark cycle in a tempera-
ture/humidity controlled facility and were given unlim-
ited access to food and water until needed.
Whole embryo culture (WEC) was performed as fully
described elsewhere (Sadler, 1979). On GD 8.0, mice
were euthanized, and uteri were removed. In Tyrode’s
buffer (Sigma, St. Louis, MO), each uterus was dissected
to remove each implantation site. Maternal tissues and
Reichert’s membranes were carefully removed to leave
a conceptus with an intact visceral yolk sac. At this
stage, embryos had three to six pairs of somites. Concep-
tuses were placed in culture medium consisting of heat-
inactivated rat serum and Tyrode’s buffer (3:1) supple-
mented with antibiotics (penicillin and streptomycin). Up
to five conceptuses were placed into 5ml of media. Bottles
were fitted into a constant gassing rotating culture device
(BTC Engineering, Cambridge, UK) heated to 37◦C and
gassed with 5% O2, 5% CO2, and 90% N2 for 20–22 hr.
At GD 8.5 (12 hr after the initiation of WEC), some con-
ceptuses were treated with 10 Mdithiole-3-thione (D3T),
a known inducer of Nrf2 and the antioxidant response,
overnight (∼12 hr). The next morning (GD 9) culture bot-
tle media and headspace were saturated with 20% O2, 5%
CO2, and 75% N2. Embryos were treated with 200 M
H2O2 by direct addition to the culture medium 2 hr af-
ter the gas change. Sample embryos were first collected
before the 200 M hydrogen peroxide (H2O2) treatment
(0min), and at 5-, 15-, 30-, 60-, and 120-min intervals there-
after for subsequent analyses. Data presented are a re-
sult of four independently performed experiments. The
values for each time point represent the average from all
four independently performed experiments where two to
four embryos were collected and individually analyzed
for each redox couple (each data point represents 8–15
embryos). Embryonic protein values after D3T treatments
were not significantly different from untreated embryos
(data not shown).
Quantitative Real-Time PCR Analysis of
Nrf2-Regulated Genes
Embryonic RNA was collected with the RNAeasy
kit (Qiagen, Valencia, CA). Complementary DNA was
synthesized from collected RNA with the Quanti-
tect DNA synthesis kit (Qiagen) and prepared for
real-time fluorescence PCR using SYBR Green detec-
tion master mix (SABiosciences, Fredrick, MD) per
the manufacturer’s instructions in a Opticon 2 real-
time PCR cycler (BioRad, Hercules, CA). All primers
were purchased from SABiosciences specifically for real-
time PCR analyses. Genes that were measured in-
cluded NADPH quinine:oxidoreductase-1 (NQO1), heme
oxygenase-1 (HO1), glutamylcysteine ligase, catalytic
subunit (Gclc), glutamylcysteine ligase, modifier sub-
unit (Gclm), glutathione-S-transferase mu 2 (GST mu2),
peroxiredoxin-1 (Prx1), thioredoxin reductase-1 (TR1),
Trx1, peroxiredoxin-3 (Prx3), thioredoxin reductase-2
(TR2), and Trx2. -Actin was measured as a housekeeping
gene for normalization purposes. Samples were analyzed
by theCtmethod and are represented as a fold-change
from untreated embryos of the same gestational age.
Glutathione Measurements
GSH and glutathione disulfide (GSSG) were measured
by high-performance liquid chromatography with fluo-
rescence detection and are expressed as molar concentra-
tions based on cell volume (Kirlin et al., 1999). Concentra-
tions were used to calculate Eh using the Nernst equation
as previously outlined elsewhere (Jones, 2002; Jones et al.,
2002).
Thioredoxin Measurements
Thioredoxin Eh were determined using a redox im-
munoblot technique that has been previously de-
scribed elsewhere (Halvey et al., 2005; Hansen et al.,
2006). Resolution of oxidized and reduced Trx was
achieved following derivatization with 4-acetoamido-4-
maleimidylstilbene-2,2-disulphonic acid (AMS, Invitro-
gen, Carlsbad, CA) and was separated based on pro-
tein size on a nonreducing sodium dodecyl sulfate (SDS)
gel. Embryos were sonicated briefly, after which proteins
were precipitated in ice-cold trichloroacetic acid (10%)
for 30 min at 4◦C then centrifuged. Pellets were washed
with 100% acetone and centrifuged. Pellets were then dis-
solved in lysis/derivatization buffer [20 mM Tris/HCl,
pH 8, 15 mM AMS with 1% SDS] and incubated at room
temperature for 3 hr in the dark. Oxidized and reduced
Trx were separated on an SDS/15% polyacrylamide gel in
the presence of nonreducing loading buffer. Trx1 and Trx2
detection was performed on separate gels. Immunoblot-
ting was performed onto nitrocellulose and detection uti-
lized a goat anti–human Trx1 primary antibody (Amer-
ican Diagnostica, Greenwich, CT) and a rabbit anti-Trx2
as the primary antibody. Secondary antibodies were the
AlexaFluor 680 nm donkey anti-goat and goat anti-rabbit
(Invitrogen) for Trx1 and Trx2, respectively. Membranes
were scanned with and Odyssey infrared scanner (Li-Cor,
Lincoln, NE). Densitometric values were collected with
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the Odyssey scanning software and Eh were determined
using band intensities and the Nernst equation, where Eo
was −254 mV for Trx1 at pH 7.4 and −330 mV for Trx2 at
pH 7.6.
Statistics
Statistical analysis was performed using SigmaStat 2.0
software (Jandel Scientific, San Rafael, CA). Differences
in fold expression of genes, GSH Eh, Trx1 Eh, and Trx2
Eh were determined by one-way ANOVA fallowed by
Tukey’s post hoc test. Significant difference were estab-
lished where p < 0.05.
RESULTS
Nrf2-regulated genes are upregulated by D3T in the
embryo. Both NQO1 and HO1 were significantly in-
creased with D3T treatments (Fig. 1). Activation of these
genes are classic hallmarks of Nrf2 activation and induc-
tion ranged between two- and threefold increases as com-
pared to untreated embryos of similar gestational age and
stage. Glutathione related genes, namely, Gclc, Gclm, and
GST mu2, also were highly upregulated, with observed
expression increases of 2.5- to 3.5-fold as elicited by D3T
treatments. Expression of Prx1, TR1, and Trx1, comprising
the principal components of the Trx1 system and largely
found in the cytoplasm, were also significantly elevated.
Similarly, the primary redox components of themitochon-
drial thioredoxin system, Prx3, TR2, and Trx2, were also
significantly upregulated.
GSH Redox Status
Total GSH and GSSG concentrations were not directly
affected byD3T treatment before the challengewithH2O2,
Fig. 1. Gene expression changes on known Nrf2 gene fol-
lowing a 14-hr treatment with 10 M dithiole-3-thione (D3T)
in gestational day (GD) 8.5 embryos. Changes in expression
are denoted as fold changes from untreated embryos of the
same gestational age. NQO1 (NADPH:quinone oxidoreductase-
1), HO1 (heme oxygenase-1), Gclc (gamma glutamylcysteinyl
ligase, catalytic subunit), Gclm (gamma glutamylcysteinyl lig-
ase, modifier subunit), GST mu2 (glutathione-S-transferase
mu 2), Prx1 (peroxiredoxin-1), TR1 (thioredoxin reductase-1),
Trx1 (thioredoxin-1), Prx3 (peroxiredoxin-3), TR2 (thioredoxin
reductase-2), and Trx2 (thioredoxin-2) were measured via real-
time PCR as outlined in “Methods” section. Data represent 8–12
embryos per group from four separately performed experiments.
Expression of these genes were significantly higher due to D3T
treatments (p < 0.05).
Fig. 2. Glutathione-related changes in embryos following H2O2
treatments with and without dithiole-3-thione (D3T) pretreat-
ment over a 120-min period. (A) glutathione (GSH) and (B) glu-
tathione disulfide (GSSG) concentrations are expressed as micro-
molar concentrations based on HPLC measurements. (C) GSH
redox potentials expressed as millivolts (mV). Conceptuses pre-
treated with D3T showed less disruption of GSH redox status
with H2O2 treatments compared to embryos not receiving the
D3T pretreatment. Data represent 8–15 embryos per group from
four separately performed experiments. Asterisks (*) denote a
statistically significant difference (p < 0.05) from Eh at time 0, be-
fore H2O2 treatment.
although in D3T-treated embryos basal GSSG appeared to
be slightly increased (Fig. 2A, B). This change did not re-
sult in significant differences in Eh. With H2O2 treatments,
embryos that were not pretreated exhibited a decrease of
GSH and a concomitant increase of GSSG, resulting in an
oxidation of embryonic GSH Eh. This oxidation occurred
quickly (5 min) and remained significantly oxidized for
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Fig. 3. Thioredoxin-1 redox changes in embryos following H2O2
treatments with and without dithiole-3-thione (D3T) pretreat-
ment over a 120-min period. (A) Trx1 redox states were deter-
mined via redox Western techniques (see “Methods” section) to
separate oxidized and reduced Trx1. (B) Using band densitome-
try, Trx1 redox potentials were determined and expressed as mil-
livolts (mV). Trx1 was oxidized by H2O2 treatments that did not
rebound over 120 min after commencement of oxidant treatment.
Pretreatment of embryos with D3T treatments, prevented H2O2-
induced oxidation of Trx1 even at early time points. Data rep-
resent 8–15 embryos per group from four separately performed
experiments. Asterisks (*) denote a statistically significant differ-
ence (p < 0.05) from Eh at time 0, before H2O2 treatment.
60 min. At 120 min, the GSH Eh returned to baseline lev-
els. With D3T pretreatments, H2O2 treatments caused a
slight loss of GSH but produced no change in GSSG lev-
els. While these were not significantly different from base-
line levels, concentration changes were significant enough
to produce an oxidation of GSH Eh, but were much less
(+10 mV) compared to embryos not pretreated with D3T
(+22 mV). However, by 15 min, GSH Eh was completely
restored to normal values.
Thioredoxin-1 Redox Status
In control embryos, Trx1 Eh was severely oxidized by
H2O2 treatment. At 5 min, Trx1 Eh was increased by +22
mV. Interestingly, Trx1 redox status did not rebound over
the 120-minmeasurement period, but rather remained ox-
idized throughout. Conversely, with D3T pretreatment,
embryos were fully resistant to H2O2 treatment, where
Trx1 Eh were unchanged even at the earlier time points
(Fig. 3).
Thioredoxin-2 Redox Status
Trx2 from embryos that did not receive the D3T pre-
treatments showed an oxidation after H2O2 treatments.
Fig. 4. Thioredoxin-2 redox changes in embryo following H2O2
treatments with and without dithiole-3-thione (D3T) pretreat-
ment over a 120-min period. (A) Trx2 redox states were deter-
mined via redox Western techniques (see “Methods” section) to
separate oxidized and reduced Trx2. (B) Using band densitome-
try, Trx2 redox potentials were determined and expressed as mil-
livolts (mV). Unlike Trx1, Trx2 redox states did rebound after 30
min andwas completely restored by 60min in embryos that were
not pretreated with D3T. With D3T pretreatments, embryos were
not affected byH2O2 treatments and remained similar to baseline
levels. Data represent 8–15 embryos per group from four sepa-
rately performed experiments. Asterisks (*) denote a statistically
significant difference (p < 0.05) from Eh at time 0, before H2O2
treatment.
Trx2 Eh remained significantly oxidized (up to +22 mV)
for 30 min until the 60 min time point where it rebounded
back to baseline Eh values. With D3T pretreatments, Trx2
was fully protected and no observable oxidation was de-
tected (Fig. 4).
DISCUSSION
Changes in redox status are known to activate or de-
activate transcription factors. Excessive oxidation of re-
dox couples alters intracellular environments where pro-
teins are susceptible to oxidative modification. Activator
protein-1 (AP-1) contains a redox-sensitive cysteine
residue that modulates its DNA binding (Abate et al.,
1990). In embryos, depletion of GSH causes excessive
AP-1 activation, increasing related gene expression while
promoting concomitant dysmorphogenesis (Ozolins and
Hales, 1997; Ozolins et al., 2002). Similarly, nuclear factor-
kappa B (NF-B) also contains cysteine residues in its
DNA-binding domain that regulates its gene transac-
tivation activity (Matthews et al., 1992). Interestingly,
thalidomide embryotoxicity has been hypothesized to be
mediated through ROS-induced dysregulation of NF-B
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(Hansen et al., 2002; Hansen andHarris, 2004). While both
of these factors are important for normal development,
they serve as examples of redox dysregulation of normal
signaling that can occur in the embryo. Based on con-
cepts developed in lower organisms and now applied to
mammals, there are likely many other proteins that are
susceptible to oxidative dysregulation in the embryo that
may have equally detrimental outcomes during periods
of oxidative stress (Allen and Balin, 1989; Hitchler and
Domann, 2007).
Clearly, maintenance of normal, stage-specific redox
states is important to allow normal signaling and devel-
opment. However, the compartmental, subcellular nature
of an oxidation may serve to promote specific responses.
For example, Trx2 has been shown to be a critical factor
for the regulation of mitochondrial function and mem-
brane permeability transition (He et al., 2008). Other stud-
ies have shown that Trx2 prevents oxidant-induced apop-
tosis, and thus, periodic oxidation of Trx2 may serve as
a means to promote apoptosis (Chen et al., 2002). Here,
we demonstrate that the embryo re-regulated Trx2 redox
status by 60 min, but it will require further study to deter-
mine if a 60min Trx2 oxidation during this developmental
stage has any detrimental downstream consequences.
Our data presented here show that both GSH and Trx2
rebound at approximately the same rate, suggesting that
pathways regulated by these two redox couples are dys-
regulated for a short period of time (30–60 min) at this
stage of development. Although GSH and Trx2 redox
states are restored over time, the undesired changes to
redox-sensitive signaling pathways are likely to occur on
amore temporary basis. It is unclear, how thesemore tran-
sient redox shifts affect differentiation/development, but
periods of sustained oxidation are likely to produce more
profound effects in the embryo.
Our data show that Trx1 does not rebound but rather
remains oxidized for at least 120 min after H2O2 treat-
ment. Trx1 is a critical protein oxidoreductase that has
been shown to participate in the regulation of critical cys-
teine residues in many proteins, including transcription
factors, such as NF-B, AP-1, and others (Mitomo et al.,
1994; Jayaraman et al., 1997). Trx1’s role occurs primarily
through the redox control of redox factor-1 (Ref1). Ref1
is a nuclear protein that functions as a DNA repair en-
zyme AP endonuclease but also interacts with transcrip-
tion factors to regulate their redox states and activity (Seki
et al., 1991; Xanthoudakis and Curran, 1996; Nishi et al.,
2002). After reducing its target, Ref1 becomes oxidized
but can be recycled back to its reduced form through Trx1
(Hirota et al., 1997). Oxidized Trx1 is then reduced by TR1
to allow further oxidoreductase activity. In control, un-
treated embryos, we observed sustained oxidation in the
embryo with peroxide treatment, suggesting that many
Trx1-dependent processes, such as transcription factor ac-
tivities, are likely to become altered during periods of
oxidative stress where Trx1 redox states are pertrubed,
promoting faulty signaling and possibly leading to em-
bryonic malformation.
Nrf2 has been implicated in mediating the acute tox-
icities produced in many tissues, including those found
in the embryo. Prior activation of Nrf2 by D3T or (-)-
epigallocatechin-3-gallate (EGCG) was shown to protect
embryos from ethanol-induced embryotoxicity in utero
(Dong et al., 2008; Long et al., 2010). Moreover, treatment
with another Nrf2 activator, tert-butylhydroperoxide
(tBHQ), provided protection against ethanol in neural
crest cells, a target of ethanol in embryos (Yan et al., 2010).
Studies have shown that embryonic exposure to ethanol
increases ROS generation, markers of oxidative damage,
and a loss of reduced GSH (Henderson et al., 1999; Akella
et al., 2000; Long et al., 2010), but these studies have failed
to delineate the duration of oxidative stress, degree of re-
dox imbalance and recovery profiles in the embryo. Here,
we show that not only do different redox couples have
very different recovery kinetics but much of the effects of
oxidants may also be prevented through Nrf2 activation.
Clearly, further work is needed to characterize and under-
stand the role of Nrf2 during development and in adapt-
ing to environmental and chemical influences on the em-
bryo proper.
Activation of Nrf2 through D3T treatment prevents
prolonged periods of oxidation and in many cases pre-
vents any oxidation following oxidant treatments in vitro.
Nrf2-mediated protection from prolonged periods of re-
dox imbalance, especially with Trx1, may serve as a
means to inhibit oxidative stress-mediated teratogenesis.
These studies suggest that many harmful substances that
are ubiquitous in the environment (i.e., heavy metals,
pesticides, etc.) that may promote teratogenesis through
an ROS-mediated mechanism may be mitigated through
proper diet and nutritional supplementation. Currently,
these recommendations are poorly delineated, but should
serve as a focus of research to protect the embryo from
insult.
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